Vigil Neuroscience Alternatives & Competitors
12 companies similar to Vigil Neuroscience — Harnessing the power of microglia to transform treatments for neurodegenerative...
Companies similar to Vigil Neuroscience
Neumora
Pioneering a new era of medicines for brain diseases
Watertown, United States
ESCAPE Bio
A CLINICAL-STAGE COMPANY DEVELOPING NOVEL, PRECISELY TARGETED THERAPIES FOR GENETIC NEUROD...
South San Francisco, Unit...
Visterra Inc.
We bring better biologics to life. Biospace Best Place to Work 2024!
Waltham, United States
Alector
We are on a mission to make brain disorders history.
South San Francisco, Unit...
Rival Readout
Competing with Vigil Neuroscience? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
-logo.jpg "Kineta (Reverse Merger With Yumanity Therapeutics)"){kind=logo}
Kineta (Reverse Merger With Yumanity Therapeutics)
Pioneering new horizons in neurodegenerative disease treatment by addressing protein misfo...
Implicit Bioscience
Implicit Bioscience is developing groundbreaking immunotherapy treatments for serious, oft...
Australia
Chase Pharmaceuticals
Pioneering advancements in neuropsychiatric treatment for a brighter future
BIORCHESTRA Co., Ltd.
We develop novel RNA-based therapeutics that will be able to bring about a paradigm shift...
Cambridge, United States
Avidity Biosciences, Inc.
At Avidity, we are developing a new class of oligonucleotide-based therapies.
San Diego, United States
Cognition Therapeutics, Inc.
Advancing Accessible Solutions for Complex Neurodegenerative Diseases
United States
Neurotrope Inc.
Developing a new approach to combating Alzheimer's disease and other neurodegenerative dis...
New York, United States
Verge Labs
Better drugs, faster. For patients who can’t wait.
San Francisco, United Sta...
About Vigil Neuroscience
Vigil Neuroscience is a clinical-stage biotechnology company established in 2020 with a focus on developing treatments for neurodegenerative diseases. The company's slogan, "Harnessing the power of microglia to transform treatments for neurodegenerative diseases," underlines its innovative approach. Vigil Neuroscience...
Neurodegenerative Diseases, Microglia, Clinical-stage, Therapeutic Modalities, Precision-based Therapies, Monoclonal Antibodies, TREM2 Agonist, Alzheimer's Disease, Series A Funding, Neuroscience, Drug Development, Phase 1 Studies, IND, Pipeline Expansion
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Vigil Neuroscience: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Vigil Neuroscience on 9 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 23 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
